Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BCL-2 protein family: attractive targets for cancer therapy
Deeksha Kaloni, Sarah T. Diepstraten, Andreas Strasser, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 20-38
Open Access | Times Cited: 270

Showing 1-25 of 270 citing articles:

Lighting up metastasis process before formation of secondary tumor by phosphorescence imaging
Kai Chang, Leyi Xiao, Yuanyuan Fan, et al.
Science Advances (2023) Vol. 9, Iss. 20
Open Access | Times Cited: 56
Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy
Ryungsa Kim, Takanori Kin, William T. Beck
Cancers (2024) Vol. 16, Iss. 5, pp. 984-984
Open Access | Times Cited: 20
Modulating Nitric Oxide: Implications for Cytotoxicity and Cytoprotection
И. Ф. Беленичев, Olena Popazova, Nina Bukhtiyarova, et al.
Antioxidants (2024) Vol. 13, Iss. 5, pp. 504-504
Open Access | Times Cited: 20
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
Biphenyl-dihydrothiazole-cyclized peptide libraries for peptide ligand and drug discovery
Jun-Jie Liu, Xiangnan Sun, Jie Zhuang, et al.
Science China Chemistry (2025)
Closed Access | Times Cited: 3
Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 2
Therapeutic Potential of Bioactive Components from Scutellaria baicalensis Georgi in Inflammatory Bowel Disease and Colorectal Cancer: A Review
Jung Yoon Jang, Eunok Im, Nam Deuk Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1954-1954
Open Access | Times Cited: 33
The emerging role of PANoptosis in cancer treatment
Yongai Xiong
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115696-115696
Open Access | Times Cited: 26
Apoptotic signaling: Beyond cell death
Maddalena Nano, Denise J. Montell
Seminars in Cell and Developmental Biology (2023) Vol. 156, pp. 22-34
Open Access | Times Cited: 22
Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules
Iksen Iksen, Wasita Witayateeraporn, Besse Hardianti, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 5, pp. 2249-2275
Closed Access | Times Cited: 13
Beta-elemene: A phytochemical with promise as a drug candidate for tumor therapy and adjuvant tumor therapy
Yewen Feng, Qingwen An, Zhengqi Zhao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116266-116266
Open Access | Times Cited: 12
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 12
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
Digant Nayak, Dongwen Lv, Yaxia Yuan, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 9
LINC complex protein nesprin-2 has pro-apoptotic activity via Bcl-2 family proteins
Liora Lindenboim, Hila Zohar, Gregg G. Gundersen, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions
Hongguang Deng, Yu Han, Liang Liu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 5963-5998
Closed Access | Times Cited: 8
The Application of Newcastle Disease Virus (NDV): Vaccine Vectors and Tumor Therapy
Huiming Yang, Jiaxin Tian, Ye Zhao, et al.
Viruses (2024) Vol. 16, Iss. 6, pp. 886-886
Open Access | Times Cited: 8
The multi-target mechanism of action of Selaginella doederleinii Hieron in the treatment of nasopharyngeal carcinoma: a network pharmacology and multi-omics analysis
Huaguo Liang, Caifu Fang, Meng Qiu
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Precision Oncology, Signaling Pathways Reprogramming and Targeted Therapy: A Holistic Approach to Molecular Cancer Therapeutics
Manish Kumar
(2025)
Closed Access | Times Cited: 1
CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance
Ki-Fong Man, Omeed Darweesh, Jinghui Hong, et al.
Oncogene (2025)
Open Access | Times Cited: 1
Contextual computation by competitive protein dimerization networks
Jacob Parres-Gold, Matthew E. Levine, Benjamin Emert, et al.
Cell (2025)
Open Access | Times Cited: 1
Self-assembled genistein nanoparticles suppress the epithelial-mesenchymal transition in glioblastoma by targeting MMP9
Qingyu Zhao, Yong Li, Qian Sun, et al.
Materials Today Bio (2025) Vol. 31, pp. 101606-101606
Open Access | Times Cited: 1
Mechanisms of action of the BCL-2 inhibitor venetoclax in multiple myeloma: a literature review
Qiang Cao, Xinyan Wu, Qi Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top